To study the comparative clinical effect of Anutaila pratimarsha nasya with shirisha avaleha and Bhastrika pranayam with jalaneti in Patients of Vataja Pratishyaaya (Allergic rhinitis)

Phase 2

• Conditions: Health Condition 1: J308- Other allergic rhinitis

• Registration Number: CTRI/2022/01/039190
• Lead Sponsor: All India Institute of Ayurveda

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2023

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Age group 16 to 50 years irrespective of their sex.

2.Patients having 4 or more diagnostic symptoms of Vataja Pratishyaya i.e.

I. Kshavathu (sneezing)

II. Nasasrava (rhinorrhea)

III.Nasauparodha (nasa blockage)

IV. Mukhashosha (dry mouth)

V. Shirashoola (headache)

VI. Nasaâ??bru kandu (itchy nose â??eyebrow)

for a minimum of one year immediately preceding the study-Screening Visit.

Exclusion Criteria

1. Patients having lower respiratory tract infection.

2. Upper Respiratory complaints such as Nasal polyposis, Nasal tumours.

3. Patients with adenotonsillar hypertrophy, craniofacial syndromes, or neuromuscular diseases.

4. Patients with history of nasal surgery.

5. Other respiratory infectious conditions such as Tuberculosis, Pleural effusion, Emphysema, Lung abscess, Bronchiectasis, Pneumonia, Pleurisy.

6. Congenital anomalies of respiratory tract or rhinitis due to trauma.

7. Patients suffering from chronic debilitating diseases like HIV, Hepatitis B, immune compromised etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Reduction in the severity of cardinal feature of Vataja Pratisyaya w.r.t allergic rhinitis.Timepoint: 2nd,4th, 6th and 8th week

Secondary Outcome Measures

Name	Time	Method
1. Decrease in the nasal smear eosinophil count and IgE level. <br/ ><br>2. Improvement in Average Daily Subject Reported AM and PM Reflective Total Nasal Symptom Scores (rTNSS) Over 0 â?? 4 weeks Treatment Period .[Time Frame: 0-4 weeks]. <br/ ><br>3. Improvement in in Average Daily Subject-reported AM and PM Reflective Total Ocular Symptom Scores (rTOSS) Over the 0 â?? 4 week Treatment Period. [Time Frame: Weeks 0 - 4] <br/ ><br>Timepoint: 0 weeks, 4 weeks